[HTML][HTML] Identification and validation of a prognostic prediction model of m6A regulator-related LncRNAs in hepatocellular carcinoma
C Jin, R Li, T Deng, J Li, Y Yang, H Li… - Frontiers in Molecular …, 2021 - frontiersin.org
Hepatocellular carcinoma (HCC) is a highly invasive malignancy prone to recurrence, and
patients with HCC have a low 5-year survival rate. Long non-coding RNAs (lncRNAs) play a …
patients with HCC have a low 5-year survival rate. Long non-coding RNAs (lncRNAs) play a …
[HTML][HTML] Identification and Validation of a Prognostic Prediction Model of m6A Regulator-Related LncRNAs in Hepatocellular Carcinoma
C Jin, R Li, T Deng, J Li, Y Yang, H Li… - Frontiers in Molecular …, 2021 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is a highly invasive malignancy prone to recurrence, and
patients with HCC have a low 5-year survival rate. Long non-coding RNAs (lncRNAs) play a …
patients with HCC have a low 5-year survival rate. Long non-coding RNAs (lncRNAs) play a …
Identification and Validation of a Prognostic Prediction Model of m6A Regulator-Related LncRNAs in Hepatocellular Carcinoma
C Jin, R Li, T Deng, J Li, Y Yang, H Li, K Chen, H Xiong… - 2021 - agris.fao.org
Hepatocellular carcinoma (HCC) is a highly invasive malignancy prone to recurrence, and
patients with HCC have a low 5-year survival rate. Long non-coding RNAs (lncRNAs) play a …
patients with HCC have a low 5-year survival rate. Long non-coding RNAs (lncRNAs) play a …
Identification and Validation of a Prognostic Prediction Model of m6A Regulator-Related LncRNAs in Hepatocellular Carcinoma.
C Jin, R Li, T Deng, J Li, Y Yang, H Li… - Frontiers in Molecular …, 2021 - europepmc.org
Hepatocellular carcinoma (HCC) is a highly invasive malignancy prone to recurrence, and
patients with HCC have a low 5-year survival rate. Long non-coding RNAs (lncRNAs) play a …
patients with HCC have a low 5-year survival rate. Long non-coding RNAs (lncRNAs) play a …
Identification and Validation of a Prognostic Prediction Model of m6A Regulator-Related LncRNAs in Hepatocellular Carcinoma
C Jin, R Li, T Deng, J Li, Y Yang, H Li… - Frontiers in …, 2021 - pubmed.ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is a highly invasive malignancy prone to recurrence, and
patients with HCC have a low 5-year survival rate. Long non-coding RNAs (lncRNAs) play a …
patients with HCC have a low 5-year survival rate. Long non-coding RNAs (lncRNAs) play a …